VitaNova Life Sciences (VNOV) Net Margin (2017 - 2026)

VitaNova Life Sciences has disclosed Net Margin across 7 years of filings, most recently posting 30.01% for Q3 2026.

• Net Margin for Q3 2026 came in at 30.01%, up 1455.0% year-over-year; the trailing twelve-month figure through Jul 2026 was 2.7% (down 3505.0% YoY), and the FY2026 annual result was 1.23%, down 3319.0% from the prior year.
• Net Margin for Q3 2026 stood at 30.01%, down from 0.98% in the prior quarter.
• Across five years, Net Margin topped out at 40.98% in Q2 2025 and bottomed at 245.77% in Q1 2023.
• Average Net Margin over 5 years is 22.03%, with a median of 8.38% recorded in 2025.
• The widest annual swing landed in 2023, when Net Margin sank 27549 bps; it then soared 26856 bps in 2024.
• Year by year, Net Margin stood at 26.01% in 2022, then sank by 662 bps to 146.17% in 2023, then surged by 108 bps to 11.18% in 2024, then retreated by 25 bps to 8.38% in 2025, then plunged by 458 bps to 30.01% in 2026.
• The last three Net Margin figures came in at 30.01% (Q3 2026), 0.98% (Q2 2026), and 6.25% (Q1 2026), per Business Quant data.